Annual report pursuant to Section 13 and 15(d)

Long-Term Debt and Other Arrangements (Details)

v2.4.0.6
Long-Term Debt and Other Arrangements (Details)
12 Months Ended 6 Months Ended 12 Months Ended 1 Months Ended 12 Months Ended 12 Months Ended
Dec. 31, 2012
USD ($)
Dec. 31, 2011
USD ($)
Dec. 31, 2010
USD ($)
Dec. 31, 2012
Novartis Note [Member]
USD ($)
Dec. 31, 2011
Novartis Note [Member]
USD ($)
Dec. 31, 2010
Novartis Note [Member]
USD ($)
Jul. 15, 2013
Servier Loan [Member]
Jan. 15, 2013
Servier Loan [Member]
Jul. 15, 2012
Servier Loan [Member]
Jan. 15, 2012
Servier Loan [Member]
Dec. 31, 2012
Servier Loan [Member]
USD ($)
Dec. 31, 2011
Servier Loan [Member]
USD ($)
Dec. 31, 2010
Servier Loan [Member]
USD ($)
Dec. 31, 2011
Servier Loan [Member]
EUR (€)
Sep. 30, 2012
General Electric Capital Corporation Term Loan [Member]
USD ($)
Dec. 31, 2012
General Electric Capital Corporation Term Loan [Member]
USD ($)
Dec. 31, 2011
General Electric Capital Corporation Term Loan [Member]
USD ($)
Dec. 31, 2010
General Electric Capital Corporation Term Loan [Member]
USD ($)
Sep. 27, 2012
General Electric Capital Corporation Term Loan [Member]
USD ($)
Dec. 31, 2012
Other Financings [Member]
USD ($)
Dec. 31, 2011
Other Financings [Member]
USD ($)
Dec. 31, 2010
Other Financings [Member]
USD ($)
Debt Instrument [Line Items]                                            
Maturity date       Jun. 30, 2015                       Jun. 15, 2015            
Research and development expenses funded through loan facility, maximum (in hundredths)       75.00%                                    
Maximum borrowing capacity under loan agreement       $ 50,000,000                   € 15,000,000                
Variable rate basis       six-month LIBOR             Euro Inter-Bank Offered Rate ("EURIBOR")                      
Basis spread on variable rate (in hundredths)       2.00%                                    
Interest rate at period end (in hundredths)       2.51%                                    
Outstanding principal balance       14,400,000 14,000,000           19,800,000         12,500,000 10,000,000   3,100,000      
Periodic Payment, Principal                             347,222              
Accrued interest (1,186,000) (1,023,000) (353,000) 400,000 300,000 400,000                                
Proceeds from loan                       19,500,000     4,600,000              
Increase (Decrease) in term loan obligation                             12,500,000              
Initial interest rate during period (in hundredths)                     3.22%                      
Interest rate during period (in hundredths)             2.33% 2.80% 3.54% 3.83%                        
Unrealized foreign exchange gain (loss) (295,000) (513,000) 0               400,000 100,000                    
Unrealized foreign exchange gains related to re-measurement of loan discount                     100,000 600,000                    
Unamortized discount on debt                     8,900,000                      
Amortization period for loan discount                     5 years                      
Amortization of debt discount                     1,400,000 1,400,000                    
Carrying value of the loan                     14,200,000                      
Recognition of deferred revenue                     1,400,000 1,400,000                    
Debt issuance costs                             200,000 1,300,000            
Final payment fee                               500,000     875,000      
Fixed interest rate accrued (in hundredths)                               11.71%     10.90%      
Number of monthly installments                             27 42            
Prepayment premium year one (in hundredths)                               3.00%            
Prepayment premium year two (in hundredths)                               2.00%            
Prepayment premium year thereafter (in hundredths)                               1.00%            
Aggregate number of unregistered shares of common stock called by warrants (in shares)                               263,158     39,346      
Warrants exercise price (in dollars per share)                               $ 1.14     $ 3.54      
Immediate Term for warrants exercisable (in years)                             5 years 5 years            
Fair value of warrant liability                               200,000     100,000      
Aggregate future principal and final fee payments of total interest bearing obligations - long-term [Abstract]                                            
2012 3,472,000                                          
2013 4,167,000                                          
2014 20,167,000                                          
2015 19,823,000                                          
Long-term debt including current portion 47,629,000                                          
Less current portion (3,472,000)                                          
Total long-term debt 44,157,000                                          
Interest expense and amortization of debt issuance costs [Abstract]                                            
Interest expense $ 4,387,000 $ 2,462,000 $ 385,000 $ 397,000 $ 341,000 $ 354,000         $ 2,097,000 $ 2,087,000 $ 0     $ 1,850,000 $ 0 $ 0   $ 43,000 $ 34,000 $ 31,000